19 research outputs found
Elevated values of cardiac troponin I in patients with coronary disease verified with computed tomography coronary angiography, preliminary results
COMORBIDITIES IN PATIENTS WITH MULTIPLE SCLEROSIS IN CROATIA
Background: Comorbidities in multiple sclerosis (MS) have a big role in management of this chronic demyelinating neurodegenerative
disorder. The aim of this study was to evaluate comorbidities in patients with MS in Croatia.
Subjects and methods: This was a prospective cross-sectional study carried out in an out-patient setting at a tertiary
healthcare centre over 10 months, which included 101 consecutive patients with MS (mean age 42.09 (range 19-77) years, 75
female, 26 male, EDSS score 3.1 (range 0.0- -42) years.
Thirty-six patients were treated with disease modifying therapies (DMTs). Information on comorbidities was obtained during the
medical interview. Data was analysed using software package IBM Corp. Released 2015. IBM SPSS Statistics for Windows,
Version 23.0. Armonk, NY: IBM Corp.
Results: 33% (n=34) patients did not have any comorbidities, and there is an equal number of patients (n=34, 33%) that just had
one comorbidity. 17.6% (n=18) of patients had two comorbidities, and 15.7% (n=16) three or more comorbidities. The most frequent
comorbidity was depression found in 25 (24.75%) patients (19 (18.8%) women, 6 (5.9%) men), followed by the hypertension in
12.87% (n=13). Hyperlipidemia and migraine were each found in 6.93% (n=7), and hypothyreosis and arrhythmia each in 3.96%
(n=4). The number of the comorbidities was found to significantly increase with the duration of MS (r=0.232, p=0.037). Women
were found to have significantly bigger numbers of comorbidities than men (t=-2.59, df=74, p<0.05). Older patients with MS were
found to have significantly more comorbidities (r=0.335, p<0.01).
Conclusions: This study gives insight into the presence of comorbidities in Croatian patients with MS. Connection with
comorbidities must be considered when managing patients with MS. Any other comorbidity in MS may also affect the condition of the
patient in general, and also their quality of life, and requires a tailored approach in management
SEXUAL DYSFUNCTION AND DEPRESSION IN PATIENTS WITH MULTIPLE SCLEROSIS IN CROATIA
Background: Both depression and sexual dysfunction (SD) may be present in patients with multiple sclerosis (MS).
Objective: The aim of this study was to evaluate a possible association between SD and depression in patients with MS in Croatia.
Subjects and methods: This was a prospective cross-sectional study carried out in tertiary healthcare centre over 10 months,
which included 101 consecutive pwMS (mean age 42.09 (range 19-77) years, 75 female, 26 male, EDSS score 3.1 (range 0.0-7.0)).
SD was assessed using Multiple Sclerosis Intimacy and Sexuality Ques tionnaire (MSISQ), which was for this purpose successfully
translated and validated into Croatian. Information on treatment for depression was obtained during the medical interview. Data
were analysed and interpreted using parametric statistics (IBM Corp. Released 2015. IBM SPSS Statistics for Windows, Version
23.0. Armonk, NY: IBM Corp.).
Results: 89 patients completed MSISQ. 25 patients were in treatment for depression, while 75 did not have depressive symptoms.
On MSISQ 57 (43women, 14 men) patients had responded with āalmost always/ alwaysā suggestive of SD. Majority of patients
reported primary SD, followed by secondary and tertiary SD. Most difficulties were found regarding difficulty in getting or keeping a
satisfactory erection (34.6% (N=9) men), followed by 32.9% (N=27) reporting that it takes too long to orgasm or climax, followe d
with bladder or urinary symptoms in 32.6% (N=29). There were no significant differences between female and male patients re-
garding treatment for depression ( Ȥ2=0.018, df=1, p>0.05). Results in all subcategories on t-test found that depressive patients had
higher impact on SD when compared to non-depressive: overall (t=-2.691, df=87, p<0.01) and in regards to primary (t=-2,086,
df=87, p<0.05), secondary (t=-2.608, df=87, p<0.05) and tertiary (t=-2.460, df=86, p<0.05) SD. Depressive patients on 7 questio ns
showed significantly (p<0.05) higher SD symptoms: Muscle tightness or spasms in my arms, legs, or body; Tremors or shaking in
hands or body; Pain, burning, or discomfort in their body; Feeling less attractive; Fear of being rejected sexually because of MS;
Lack of sexual interest or desire; Less intense or pleasurable orgasms or climaxes.
Conclusions: This study gives insight into the presence of depression and SD in Croatian patients with MS for which purpose
valid questionnaire for the assessment of SD in MS patients MSISQ was with permission successfully translated and validated int o
Croatian. The connection between depression and SD must be considered when managing patients with MS
ANXIETY AND DEPRESSION AS COMORBIDITIES OF MULTIPLE SCLEROSIS
Multiple Sclerosis (MS), a chronic inflammatory neurodegenerative disease, is accompanied by a number of comorbidities.
Among the psychiatric ones, depression and anxiety occupy a special place. It is estimated that the prevalence of anxiety in the MS
population is 22.1% verus 13% in the general population; whereas the prevalence of anxiety levels, as determined by various
questionnaires, reaches even 34.2%. Systematic literature reviews (SPL) show considerable data variations due to differences in
study design, sample size, diagnostic criteria and extremely high heterogeneity (I2). Among the more conspicuous factors associated
with anxiety disorder in MS are demographic factors (age and gender), nonsomatic depressive symptoms, higher levels of disability,
immunotherapy treatments, MS type, and unemployment. Depression is the most common psychiatric commorbidity in MS and the
lifetime risk of developing depression in MS patients is >50%. According to some research, the prevalence of depression in MS vary
between 4.98% and 58.9%, with an average of 23.7% (I2=97.3%). Brain versus spinal cord lesions, as well as temporal lobe,
fasciculus arcuatus, superior frontal and superior parietal lobe lesions in addition to the cerebral atrophy have been shown to be the
anatomical predictors of depressive disorder in MS. Hyperactivity of the hypothalamic-pituitary-adrenal axis (HPA) and the
consequent dexamethasone-insupressible hypercortisolemia, in addition to cytokine storm (IL-6, TNF--4) present
the endocrine and inflammatory basis for development of depression. Fatigue, insomnia, cognitive dysfunction, spasticity,
neurogenic bladder, pain, and sexual dysfunction have shown to be additional precipitating factors in development of anxiety and
depression in MS patients
LOWER URINARY TRACT SYMPTOMS AND DEPRESSION IN PATIENTS WITH MULTIPLE SCLEROSIS
Background: Both depression and lower urinary tract symptoms (LUTS) may be present in patients with multiple sclerosis (MS).
The objective of this study was to give an insight on depression and LUTS in patients with MS in Croatia and to determine the
possible association between LUTS and depression in patients with MS.
Subjects and methods: This was a prospective cross-sectional study conducted in a tertiary healthcare center in Croatia. Hundred
and one consecutive patients with MS (75 female, 26 male, mean age 42.09 (range 19-77) years, mean Expanded Disability Status
Scale (EDSS) score 3.1 (range 0.0-7.0)) participated in this study. We evaluated LUTS and related quality of life (QoL) using three International
Consultation on Incontinence Questionnaires (ICIQ) enquiring about overactive bladder (ICIQ-OAB), urinary incontinence
short form (ICIQ-UI SF) and lower urinary tract symptoms related quality of life (ICIQLUTS-QoL). ICIQ-OAB and ICIQLUTS-QoL
were for this purpose with permission successfully translated and validated into Croatian, while ICIQ-UI SF was already previously
validated for the Croatian language. Information regarding treatment for depression was obtained during the medical interview. Data
were analyzed and interpreted using IBM SPSS Statistics for Windows, version 23.0 (IBM Corp., Armonk, N.Y., USA).
Results: 89.10% (N=90) patients with MS reported urgency with urge urinary incontinence (UUI) present in 70.29% (N=71).
81.18% (N=82) patients reported nocturia, and 90.09% (N=91) reported feeling drowsy or sleepy during the day due to bladder
symptoms. Neurological deficit measured by EDSS was found to positively correlate with LUTS on all three questionnaires: ICIQOAB
(r=0.390, p<0.05), ICIQ-UI SF (r=0.477, p<0.01) and ICIQ-LUTSQoL (r=0.317, p<0.05). 25 patients were in treatment for
depression. There were no significant differences between female and male patients regarding treatment for depression (2=0.018, df=1, p>0.05). Results on ICIQ-UI SF showed that depressive patients had more pronounced LUTS (t=2.067, df=99, p<0.05), which was also true for the ICIQ-LUTSQoL (t=-2.193, df=99, p<0.05). Positive correlations were found between depression and LUTS on ICIQ-UI SF (r=0.203, p<0.05) and ICIQ-LUTSQoL (r=0.215, p<0.05).
Conclusion: This study gives insight into the presence of depression and LUTS in Croatian patients with MS for which purpose
ICIQ-OAB and ICIQ-LUTSQoL were with permission successfully translated and validated into Croatian. The connection between depression and LUTS must be considered when managing patients with MS
KliniÄka istraživanja u zemljama u razvoju - etiÄka promiÅ”ljanja
When designing clinical trial or considering decision to take part in particular clinical trial as investigators, even before submission to responsible Central Ethic Committee, we always make certain private assessment about ethical justification of this clinical trial. When making assessment if any clinical trial is ethically justifiable, there should make no difference in which country this clinical trial will be executed. Physicians coming from developing countries must ensure that patient population of developing countries is not misused in any ethically questionable clinical trial. There must be careful assessment of clinical protocols by various independent local advisory committees (e.g. hospital review boards, hospital drug committees, hospital administration and whatever is applicable) to exclude the possibility that only one person or one group of people has concentrated power to make decisions for entire country. Many times physicians/clinical researchers from developing countries are faced with the criticisms that they are not of the same quality as physicians from developed countries and that they can be easily bribed by sponsors, which are based on the prejudice that any clinical trial can be executed in developing countries, no matter of quality or risks for patients. Physicians coming from developing countries must ensure that patient population of developing countries is not misused in any ethically questionable clinical trial.Prilikom pripreme kliniÄkog istraživanja ili promiÅ”ljanja o sudjelovanju u odreÄenom kliniÄkom istraživanju kao istraživaÄi, Äak I prije centralnog etiÄkog odbora, uvijek osobno procijenimo etiÄku opravdanost tog kliniÄkog istraživanja. Prilikom procjene etiÄke opravdanosti kliniÄkog istraživanja, ne bi trebalo Äiniti nikakvu razliku to u kojoj se državi provodi kliniÄko istraživanje. LijeÄnici iz zemalja u razvoju moraju osigurati da pacijenti iz zemalja u razvoju nisu zloupotrebljeni u etiÄki upitnom istraživanju. Mora postojati detaljna procjena kliniÄkih protokola od strane raznih lokalnih savjetodavnih odbora (kaon a primjer: bolniÄka uprava, administracija, odbor za lijekove i Å”to je veÄ prikladno ) tako da bi se iskljuÄila moguÄnost da samo jedna osoba ili skupina ljudi ima svu moÄ u donoÅ”enju odluka za cijelu zemlju. LijeÄnici/kliniÄki istraživaÄi iz zemalja u razvoju Äesto se suoÄavaju s kritikama da nisu dovoljno kvalitetni kao oni iz razvijenih zemalja te da ih sponzori lako podmite, temeljeno na predrasudama o tome da kliniÄka istraživanja mogu biti provedena u zemljama u razvoju bez obzira na sigurnost pacijenata. LijeÄnici iz zemalja u razvoju moraju osigurati da pacijenti iz zemalja u razvoju nisu zloupotrebljeni u etiÄki upitnom istraživanju
Application of Specific Judo Operators in the Preparatory Part of Athlete Training : Undergraduate Thesis
U ovom radu su opisani kinezioloŔki operatori koji se primjenjuju u judo treningu, osobito s
mlaÄim dobnim kategorijama, a mogu imati svoju primjenu u velikom broju drugih sportova,
osobito u uvodno-pripremnom dijelu treninga. Svi navedeni operatori kategorizirani su u 4
skupine i viÅ”e podskupina sukladno naÄinu izvedbe (individualno ili u parovima, te u kretanju
ili u mjestu). Ovaj rad stoga može imati veliku praktiÄnu vrijednost trenerima u osmiÅ”ljavanju
i planiranju trenažnih jedinica.This final thesis describes kinesiological operators that are used in judo training, especially with
younger age categories, and can have their application in a large number of other sports,
especially in the introductory-preparatory part of training. All these operators are categorized
into 4 groups and more subgroups according to the method of performance (individually or in
pairs, and in motion or in place). This final thesis can therefore be of great practical value to
trainers in designing and planning training units
Application of Specific Judo Operators in the Preparatory Part of Athlete Training : Undergraduate Thesis
U ovom radu su opisani kinezioloŔki operatori koji se primjenjuju u judo treningu, osobito s
mlaÄim dobnim kategorijama, a mogu imati svoju primjenu u velikom broju drugih sportova,
osobito u uvodno-pripremnom dijelu treninga. Svi navedeni operatori kategorizirani su u 4
skupine i viÅ”e podskupina sukladno naÄinu izvedbe (individualno ili u parovima, te u kretanju
ili u mjestu). Ovaj rad stoga može imati veliku praktiÄnu vrijednost trenerima u osmiÅ”ljavanju
i planiranju trenažnih jedinica.This final thesis describes kinesiological operators that are used in judo training, especially with
younger age categories, and can have their application in a large number of other sports,
especially in the introductory-preparatory part of training. All these operators are categorized
into 4 groups and more subgroups according to the method of performance (individually or in
pairs, and in motion or in place). This final thesis can therefore be of great practical value to
trainers in designing and planning training units